Wachovia upgrades Abbott Laboratories (NYSE: ABT) to Outperform with a $63-$65 valuation range.

The firm said it expects Abbott's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE